Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
ContraFect Corp is a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lysin exebacase has a targeted spectrum of activity, meaning that it kills specific species of Staphylococci or closely related bacteria. Its IND candidate, CF-370, targets resistant gram-negative bacteria including Pseudomonas aeruginosa (P. aeruginosa). Its advanced clinical candidate, exebacase, is an investigational novel lysin that targets Staphylococcus aureus (Staph aureus), including methicillin-resistant (MRSA) strains, which causes serious infections such as bacteremia, pneumonia and osteomyelitis.
| Last: | $0.0001 |
|---|---|
| Change Percent: | -90.0% |
| Open: | $0.0001 |
| Close: | $0.0001 |
| High: | $0.0001 |
| Low: | $0.0001 |
| Volume: | 19,807 |
| Last Trade Date Time: | 11/03/2025 11:45:46 am |
| Market Cap: | $11 |
|---|---|
| Float: | 9,635,393 |
| Insiders Ownership: | 1.6% |
| Institutions: | 3 |
| Short Percent: | 59634% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.contrafect.com |
| Country: | US |
| City: | Yonkers |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about ContraFect Corporation (OTCMKTS: CFRXQ).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
